Concepedia

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin

Peter Ferenci, Michael Fried, Mitchell L. Shiffman, Coleman I. Smith, George Marinos, Fernando Lopes Gonçales, Dieter Häussinger, M. Diago, Daniel Dhumeaux, Monique Chaneac,

Journal of Hepatology · 2005 · 517 citations · 14 references

DOI

Concepts

References

14

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

, , +17

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

, , +17

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C

Stephanos J. Hadziyannis · Annals of Internal Medicine · 2004 · 2.8K citations

, , +17

Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C

John G. McHutchison, Michael P. Manns, Keyur Patel et al. · Gastroenterology · 2002 · 977 citations · Full text

, , +12

Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C

Gary L. Davis, John B. Wong, John G. McHutchison et al. · Hepatology · 2003 · 820 citations · Full text

, , +17